{"id":"W2050445965","doi":"10.1016/j.cgh.2013.09.006","title":"Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease","year":2013,"lang":"en","type":"review","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":299,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma; Genentech; Optimer Pharmaceuticals; Bristol-Myers Squibb; Shire; Orexigen Therapeutics; Gilead Sciences; National Park Service; Roche; AbbVie; Merck; Novartis; Pfizer","keywords":"Medicine; Crohn's disease; Crohn disease; Disease management; Disease; Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003376635,0.0004169349,0.001241101,0.0000594779,0.00008612746,0.00001228709,0.0005255292,0.0004517252,0.00004960725],"category_scores_gemma":[0.00008103151,0.0002797804,0.0007141038,0.00003866118,0.0004847877,0.000002797861,0.000385172,0.0002125295,0.00003072371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001128706,"about_ca_system_score_gemma":0.0002285025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003598365,"about_ca_topic_score_gemma":0.0000172998,"domain_scores_codex":[0.9972297,0.0003967216,0.001015474,0.0007909307,0.00006835345,0.0004988495],"domain_scores_gemma":[0.9981478,0.0001389102,0.000394565,0.0007872502,0.0000502419,0.0004812348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01333423,0.000927241,0.0304618,0.02302783,0.005965619,0.00139477,0.00002376121,0.000007521719,0.000001642881,0.003578031,0.05932886,0.8619487],"study_design_scores_gemma":[0.001348127,0.0008431547,0.01503293,0.0003974692,0.002162066,0.00005230918,0.000005346723,0.00001520048,4.078693e-7,0.00030519,0.979633,0.0002047554],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01017916,0.979988,0.003869593,0.0007745781,0.0006063933,0.004315478,0.0002016464,0.00001666423,0.00004851052],"genre_scores_gemma":[0.0006288128,0.9939192,0.00182018,0.001277947,0.0003819412,0.0007268582,0.0002308275,0.00005646084,0.0009577769],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9203042,"threshold_uncertainty_score":0.9999654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0482122491161925,"score_gpt":0.3596055154931097,"score_spread":0.3113932663769172,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}